Two Sigma Advisers’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,600
Closed -$66.4K 2042
2025
Q4
$66.4K Buy
11,600
+200
+2% +$1.23K ﹤0.01% 2267
2025
Q3
$77.7K Buy
+11,400
New +$86.3K ﹤0.01% 2246
2025
Q2
Sell
-12,800
Closed -$68.9K 2565
2025
Q1
$68.9K Buy
+12,800
New +$87K ﹤0.01% 2286
2024
Q4
Sell
-11,200
Closed -$101K 2540
2024
Q3
$101K Sell
11,200
-19,400
-63% -$200K ﹤0.01% 2163
2024
Q2
$325K Sell
30,600
-44,100
-59% -$470K ﹤0.01% 2040
2024
Q1
$658K Sell
74,700
-10,900
-13% -$88.7K ﹤0.01% 1751
2023
Q4
$584K Buy
85,600
+32,500
+61% +$267K ﹤0.01% 1856
2023
Q3
$518K Buy
+53,100
New +$425K ﹤0.01% 1776
2022
Q2
Sell
-10,400
Closed -$56K 2881
2022
Q1
$56K Sell
10,400
-3,800
-27% -$20.3K ﹤0.01% 2578
2021
Q4
$86K Buy
+14,200
New +$87.2K ﹤0.01% 2425

Other funds holding ULBI

Two Sigma Advisers's ULBI Position: Q1 2026 in Review

Two Sigma Advisers sold out of Ultralife (ULBI) in Q1 2026, closing a stake of 11,600 shares — an estimated $66.4K sold.

Two Sigma Advisers first reported a position in ULBI in Q4 2021 and held it in 10 quarters. The position peaked at $658K in Q1 2024. 50 funds tracked by Wall St. Rank hold ULBI as of Q1 2026.

  • Two Sigma Advisers reported no remaining Ultralife position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 11,600 Ultralife shares in Q1 2026, an estimated $66.4K.
  • Two Sigma Advisers first reported a position in Ultralife in Q4 2021 and held it in 10 quarters.
  • Two Sigma Advisers's Ultralife position peaked at $658K in Q1 2024.
  • 50 funds tracked by Wall St. Rank held Ultralife as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.